Repligen RGEN
NASDAQ RGEN
$179.77 -0.52 (-0.29%)
As of: Aug 21, 2026 · 11:59 AM EDT

Repligen (RGEN) EBIT Margin (2010 - 2026)

Repligen (RGEN) posted quarterly EBIT Margin of 6.85% for Q2 2026, down 77.0% year-over-year from 29.77% in Q2 2025, and down 16.56% quarter-over-quarter from 8.21% in Q1 2026.

Repligen (RGEN) EBIT Margin (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported EBIT Margin for 17 consecutive years, with 6.85% the latest figure, recorded in Q2 2026.

  • In Q2 2026, EBIT Margin fell 77.0% year-over-year to 6.85%; the TTM figure through Jun 2026 stood at 8.23% (up 1177.0% YoY), while the FY2025 annual figure was 7.47%, up 1301.0% from the prior year.
  • EBIT Margin declined to 6.85% in Q2 2026 per RGEN's latest filing, from 8.21% in the prior quarter.
  • Across five years, EBIT Margin topped out at 30.42% in Q2 2022 and bottomed at 21.79% in Q4 2024.
  • Historically, EBIT Margin has averaged 9.18% across 5 years, with a median of 7.91% in 2025.
  • Annual changes were most pronounced in 2024 — EBIT Margin tumbled 2771 bps — and 2025, when it jumped 3081 bps.
  • Repligen's EBIT Margin stood at 26.15% in 2022, then tumbled by 77 bps to 5.93% in 2023, then slumped by 468 bps to 21.79% in 2024, then soared by 141 bps to 9.03% in 2025, then fell by 24 bps to 6.85% in 2026.
  • Business Quant data shows RGEN's EBIT Margin at 6.85% in Q2 2026, 8.21% in Q1 2026, and 9.03% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Intuitive Surgical 135.11 Bn 129.89 Bn 1.96 Bn 33.60%
2 Becton Dickinson 52.56 Bn 51.69 Bn 2.32 Bn 13.31%
3 Alcon 35.75 Bn 34.40 Bn 1.68 Bn 0.39%
4 Resmed 34.02 Bn 32.55 Bn 861.22 Mn 30.66%
5 Medline 29.09 Bn 26.41 Bn 2.22 Bn 5.14%
6 West Pharmaceutical Services 24.92 Bn 24.49 Bn 329.20 Mn 20.53%
7 Solventum 15.30 Bn 14.90 Bn 1.29 Bn 8.19%
8 Cooper Companies 14.83 Bn 14.69 Bn 735.40 Mn -2.87%
9 Baxter International 13.66 Bn 11.51 Bn 1.03 Bn 7.33%
10 Repligen 10.13 Bn 9.12 Bn 110.04 Mn 6.85%

Historic Data

Download Data
DateValue
Jun 30, 2026 6.85%
Mar 31, 2026 8.21%
Dec 31, 2025 9.03%
Sep 30, 2025 8.91%
Jun 30, 2025 7.62%
Mar 31, 2025 3.89%
Dec 31, 2024 -21.79%
Sep 30, 2024 -5.06%
Jun 30, 2024 3.44%
Mar 31, 2024 2.45%
Dec 31, 2023 5.93%
Sep 30, 2023 3.32%
Jun 30, 2023 12.11%
Mar 31, 2023 8.38%
Dec 31, 2022 26.15%
Sep 30, 2022 26.24%
Jun 30, 2022 30.42%
Mar 31, 2022 29.07%
Dec 31, 2021 20.07%
Sep 30, 2021 25.36%